A new study suggests that a combination of radiation therapy and immune checkpoint inhibitors (ICIs) may offer a less invasive alternative to bladder...
Vous n'êtes pas connecté
New research has showed that the majority of patients achieving high rates of glucose control and weight loss in the first year of tirzepatide treatment have sustained success in the second year; however, factors predicting a sustained response are less clear for weight loss,. The findings are from the SURPASS-4 trial in which patients with […]
A new study suggests that a combination of radiation therapy and immune checkpoint inhibitors (ICIs) may offer a less invasive alternative to bladder...
Thomas E. Hutsonchief of the Haematology Oncology Division at Texas Tech University Health Sciences Centre, USA, has shared groundbreaking findings...
Patients prefer non-invasive neuromodulation over traditional drugs for mental health. Could this be the future of treatment? Explore the latest...
A world-first clinical trial will investigate whether the experimental treatment given to a former Australian of the year can treat aggressive tumours...
A world-first clinical trial will investigate whether the experimental treatment given to a former Australian of the year can treat aggressive tumours...
A new study suggests that even modest weight loss with GLP-1 medications like Wegovy and Zepbound can help prevent knee and hip replacements from...
Supplies of high-demand obesity treatments are improving, but that doesn’t mean it’s easier to get them. Many employers and insurers are scaling...
MONDAY, March 3, 2025 -- For patients with type 2 diabetes, chronic kidney disease, and additional cardiovascular risk factors, the dual...
Highlights: Water fasting causes temporary weight loss but leads to muscle loss and rapid weight gain Prolonged
What factors influence the success or failure of immunotherapy treatment in patients with advanced bladder cancer? Why do only 20% of advanced bladder...